TECPORT OPTICS, INC.
ORLANDO, FLORIDA

TECPORT OPTICS, INC., ORLANDO

About Tecport Optics Founded in 1997, Tecport Optics designs, manufactures, sells and services state-of-the-art thin film vacuum deposition systems to customers across the globe. Working vigorously with its world-class instrument suppliers, Tecport builds the most reliable, efficient, and flexible coating systems in the world, customized to the meet the technical specifications of a variety of industries. Dedicated to excellence in customer service and technical innovation, Tecport has built a loyal customer base that benefits from its corporate motto, “ Continuous research in advanced material science and automation technology enables Tecport to meet the high demand of the fast changing marketplace in thin film technology, whether it is ophthalmic or 3D glass, night vision goggle or solar. Tecport strives to excel in all aspect of the Total Customer Experience, from design to production, to customer service. Join Tecport in partnership to transform the world market and making the world better with innovation! Tell us about how we can help. , a vertically integrated, privately held oil and gas company in Turkey. Prior to that, Dr. Nabil El-Hag was a founding partner at Pacific Rim Technologies, Inc., where he facilitated business agreements between United States companies and government and private industry in Indonesia, China, Singapore, Vietnam and Cambodia. As a founding partner of Shore Capital, he brokered a business partnership with a leading Middle Eastern financial advisory group to purchase US companies and established business relationships across the MENA Region in the oil, mining, hospitality, construction and telecommunications industries. As a committed social entrepreneur and technocrat, he also founded and managed several other businesses and non-profit initiatives including Fresh ‘n Fit, Inc, American Family Brands, Kid’s 1 MANAGEMENT PHILOSOPHY Tecport Optics designs, manufactures, sells and services state-of-the-art thin film vacuum deposition systems to customers across the globe. Working vigorously with its world-class instrument suppliers, Tecport builds the most reliable, efficient, and flexible coating systems in the world, customized to the meet the technical specifications of a variety of industries. Dedicated to excellence in customer service and technical innovation, Tecport has built a loyal customer base that benefits from its corporate motto, New Partners MTSU, Tecport Optics May Revolutionize Medical Research, Health Care with Diagnostic Tool — Middle Tennessee State University and Tecport Optics of Orlando, Florida, have entered into a licensing agreement to commercialize the University’s biosensor technology as a medical diagnostic tool for research labs and point-of-care health professionals. From left, Tecport Optics and MTSU representatives Frank Helmes, Tecport sales, Tecport President Tam Lee, physics and astronomy professor and inventor Bill Robertson and Tecport Vice Chairman Nabil El-Hag visit in front of Kirksey Old Main at MTSU. Dr. Nabil El-Hag Rejoins Tecport Optics as Vice Chairman as Vice-Chairman of the company. “We are pleased that Dr. El-Hag has rejoined our company. He will be working closely with me on setting the strategic direction of the company, including the development of new strategic alliances that support our growth strategy. Dr. El-Hag was the architect and driving force for establishing our joint venture with the University of Utah and Axon Corporation a few years ago. He crafted the alliance that enabled us to deploy our cold plasma technology for lens applications for the treatemnt of light sensitive migraine headaches,” said Mr. Le. The products developed by Axom and Tecport have now reached the final FDA approval stage and Tecport is mobilizing their resources to capitalize on this opportunity. The US migrain market is currently estimated at $2 billion in prescription drug sales. According to a 2001 NIH report, approximately 28 million people suffer from migraines in the US, more than diabetes and asthma combined. Tecport Optics and Axon Joint Venture Participants (left to right): Dr. Steve Blair, Dr, Bradley Katz, Rich Sholtz, RPh., Esq., Tam Le, Dr. Nabil El-Hag, and Frank Helmes The application of Tecport’s “Polaris Process” is an industry break-through that allows multi-layer thin film coating on plastics. This cold plasma technology opens up a myriad of business opportunities across many market segments. “I am pleased to be working with Tecport during this exciting stage of their growth, and look forward to establishing the strategic alliances that will enable them to capitalize on this revolutionary development in optical technology,” comment Dr. El-Hag. Dr. El-Hag, an accomplished Fortune 500 executive, an experienced entrepreneur, an award winning scientist, brings over 35 years of unique experience to the venture. “His balanced approach to building value through win-win partnerships, has served us well in the past,” said Mr. Le. “We are confident that Dr. El-Hag’s leadership and business acumen will enable us to realize the tremendous opportunities that cold plasma technology brings to our industry.” Tell us about how we can help. Tell us about how we can help.

KEY FACTS ABOUT TECPORT OPTICS, INC.

Company name
TECPORT OPTICS, INC.
Status
Active
Filed Number
P97000076531
FEI Number
593471642
Date of Incorporation
September 3, 1997
Age - 27 years
Home State
FL
Company Type
Domestic for Profit

CONTACTS

Website
http://tecportoptics.com
Phones
(407) 855-1212
(407) 855-1213
(981) 110-7998

TECPORT OPTICS, INC. NEAR ME

Principal Address
6457 HAZELTINE NATIONAL DR.,
SUITE 140,
ORLANDO,
FL,
32822,
US
Mailing Address
6457 HAZELTINE NATIONAL DRIVE,
SUITE 140,
ORLANDO,
FL,
32822,
US

See Also

Officers and Directors

The TECPORT OPTICS, INC. managed by the two persons from ORLANDO, ST CLOUD on following positions: Director

Tam V Le

Position
Director Active
From
ORLANDO, 32828

Joseph Kim

Position
Director Active
From
ST CLOUD, 34771





Registered Agent is Tam V Le

From
ORLANDO, 32828

Annual Reports

2024
April 1, 2024
2023
April 10, 2023